Oct 13, 2026 06:50AM
Oct 12, 2026 07:01AM
Oct 7, 2026 07:05AM
Sep 30, 2026 10:01AM
Sep 30, 2026 07:17AM
Sep 30, 2026 05:57AM
Sep 22, 2026 07:05AM Zenas BioPharma to present obexelimab IgG4-RD data at two meetings
Sep 11, 2026 04:52PM
Aug 13, 2026 07:22AM
Jun 3, 2026 06:54AM
May 13, 2026 04:09PM
May 13, 2026 06:37AM
Mar 16, 2026 04:59PM
Mar 16, 2026 02:37PM Zenas Biopharma (ZBIO) PT Raised to $21 at Morgan Stanley ahead of BLA submission in 2Q26
Jan 6, 2026 06:44AM
Jan 6, 2026 04:59AM
Jan 5, 2026 03:41PM
Jan 5, 2026 02:19PM
Jan 5, 2026 07:00AM
Dec 16, 2025 06:58AM
Dec 15, 2025 07:05AM InnoCare drug meets primary goal in lupus trial for Zenas partner
Nov 12, 2025 04:49PM
Oct 28, 2025 06:42AM
Oct 27, 2025 12:32PM
Oct 27, 2025 11:02AM
Oct 9, 2025 06:42AM
Oct 8, 2025 04:35PM
Sep 2, 2025 07:15AM Royalty Pharma provides up to $300 million to Zenas BioPharma for obexelimab
Jul 10, 2025 05:48AM
Jul 3, 2025 07:40AM
Jun 15, 2025 12:15PM
Jun 14, 2025 10:24AM
Jun 14, 2025 10:10AM
Jun 13, 2025 10:10AM
Jun 11, 2025 09:47PM ZBIO DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Zenas BioPharma, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important June 16 Deadline in Securities Class Action
Jun 11, 2025 01:28PM
Jun 10, 2025 04:10PM
Jun 10, 2025 04:00PM
Jun 9, 2025 04:09PM
Jun 9, 2025 10:04AM
Jun 8, 2025 03:05PM
Jun 8, 2025 08:17AM INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Zenas BioPharma
Jun 7, 2025 03:00PM
Jun 6, 2025 02:55PM
Jun 6, 2025 09:53AM
Jun 5, 2025 02:50PM
Jun 4, 2025 04:00PM
Jun 3, 2025 01:35PM
Jun 3, 2025 10:40AM ZBIO Investors Have the Opportunity to Lead the Zenas BioPharma Securities Fraud Lawsuit with Faruqi & Faruqi, LLP
Jun 2, 2025 01:29PM

479,029 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All